Skip to main content
Premium Trial:

Request an Annual Quote

DuPont and Acacia Sign Profiling Deal

Premium

RICHMOND, Calif.--Acacia Biosciences and DuPont Agricultural Enterprise signed a profiling agreement to utilize Acacia's Genome Reporter Matrix, an assay-based computer modeling system that uses yeast as a miniature ecosystem, to aid in the selection and optimization of lead compounds for use in crop protection. Acacia will provide chemical and biological profiles on a class of DuPont's compounds with potential agricultural uses. The agreement is Acacia's fifth, and its second in agriculture.

Filed under

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.